Choosing the Optimum Treatment Setting for Those with Alcohol Use - - PowerPoint PPT Presentation

choosing the optimum
SMART_READER_LITE
LIVE PREVIEW

Choosing the Optimum Treatment Setting for Those with Alcohol Use - - PowerPoint PPT Presentation

Choosing the Optimum Treatment Setting for Those with Alcohol Use Disorders Robert G. Rychtarik, Ph.D. Department of Psychiatry Financial Disclaimer There are no financial conflicts to disclose. Goals Historical background on the use and


slide-1
SLIDE 1
slide-2
SLIDE 2

Choosing the Optimum Treatment Setting for Those with Alcohol Use Disorders

Robert G. Rychtarik, Ph.D.

Department of Psychiatry

slide-3
SLIDE 3

Financial Disclaimer

There are no financial conflicts to disclose.

slide-4
SLIDE 4

Goals

  • Historical background on the use and

efficacy of different treatment settings for AUD

  • Summarize findings our own work at RIA

(Rychtarik et al., 2000)

  • Present results of our effort to replicate

this work at ECMC (Rychtarik et al., 2017)

slide-5
SLIDE 5

Key Questions

  • 1. Does Inpatient Treatment for AUD Produce

Better Outcomes that Outpatient Treatment for All Comers?

a) If so, how big is the advantage?

slide-6
SLIDE 6

Key Issues (Continued)

  • 2. Does Inpatient Treatment for AUD Produce

Better Outcomes than Outpatient Treatment Among Identifiable Subgroups of Clients?

a) If so, how big is the advantage?

slide-7
SLIDE 7

Acknowledgments

Research Collaborators Neil B. McGillicuddy, Ph.D. Robert B. Whitney, M.D. Gerard J. Connors, Ph.D. George D. Papandonatos, Ph.D. Clinical Coordinator Joan Duquette Research Staff Carrie Pengelly Jean Finn Dennis Dickman Kathy Skibicki Sue Sperrazza Rebecca Eliseo-Arras Joe Hoffman Florence Leong Larry Jagodzinski Eileen Logsdon Pat Aughtry Barb Roth

slide-8
SLIDE 8

Special Acknowledgements

  • Erie County Medical Center (ECMC)

Division of Chemical Dependency

  • National Institute on Alcohol Abuse and

Alcoholism (NIAAA)

slide-9
SLIDE 9

Background

  • Mid-late 1980s reviews:
  • Outpatient (OP) = Inpatient (IP)
slide-10
SLIDE 10

American Psychologist, 41, 794-805.

slide-11
SLIDE 11

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 1990 2002 Inpatient/Residential programs Outpatient programs

Source: McLelland (2006)

The Practical Effect on Programs Available

slide-12
SLIDE 12

Percentage of Days Abstinent Month

Inpatient Outpatient

Finney & Moos (1996)

slide-13
SLIDE 13

Revisiting Inpatient Care

  • Have we thrown the baby out with

the bathwater?

  • Has the pendulum swung to far

toward outpatient treatment for all?

slide-14
SLIDE 14

Lingering Question

  • Do some individuals still benefit more from

inpatient than outpatient care?

  • Higher Problem Severity?
  • Lower Cognitive Functioning?
  • Higher Psychiatric Severity?
  • Lower Social Support Abstinence?
  • Lower Motivation?
slide-15
SLIDE 15

The RIA Study

slide-16
SLIDE 16

Our Early Work

  • RCT
  • RIA’s Clinical Research Center
  • Manualized treatment components
  • Randomization to treatment staff
  • Recruitment by advertising
slide-17
SLIDE 17

Design Features

  • N = 192
  • Randomized treatment groups to:
  • 28-day inpatient treatment + 6 mos. of

aftercare

  • 28-day intense outpatient + 6 mos. of

aftercare

  • 28-day standard outpatient + 6 mos. of

aftercare

slide-18
SLIDE 18

Hypotheses

  • Tested two a priori Client Attribute X Setting

interaction hypotheses:

  • Problem Severity:
  • Higher Severity would benefit from Inpatient
  • Lower Severity would benefit from Outpatient
  • High network support for drinking would be

associated with better outcomes in Inpatient

slide-19
SLIDE 19

Exploratory Client Attributes

  • Explored moderating effects of other Client Attributes:
  • Cognitive Functioning
  • Psychiatric severity
  • Self-efficacy
  • Motivation
slide-20
SLIDE 20

Problem Severity Attribute

  • Alcohol Use Inventory, General Alcohol

Involvement Scale score (AUI-AIS; Horn et al., 1990)

slide-21
SLIDE 21

Alcohol Involvement X Setting Interaction

slide-22
SLIDE 22

Alcohol Involvement X Setting Interaction

slide-23
SLIDE 23

Exploratory Client Attributes

  • Explored moderating effects of other Client Attributes:
  • Cognitive Functioning
  • Psychiatric severity
  • Self-efficacy
  • Motivation
slide-24
SLIDE 24

Cognitive Functioning Attribute

  • Symbol Digit Modalities Test (SDMT; Smith, 1982)
slide-25
SLIDE 25

Cognitive Functioning X Setting Interaction

slide-26
SLIDE 26

Involuntary Abstinent Days (Hospitalizations & Incarcerations)

5 10 15 20 25 Inpatient Intenstive Outpatient Standard Outpatient Percentage

slide-27
SLIDE 27

Summary of RIA Study Findings

  • Lower AUD Severity:

OP = IP

  • Higher AUD Severity:

IP > OP

  • Lower Cognitive Functioning: IP > OP
  • Involuntary Abstinent Days: IP < OP
slide-28
SLIDE 28

The ECMC Study

slide-29
SLIDE 29

Can we replicate these findings in the real-world setting of a community-based substance abuse treatment program?

slide-30
SLIDE 30

Aims

  • Primary aims:
  • Recruit through ECMC clinics & detox
  • Prospectively categorize clients as to need for

inpatient care using prior study’s cut-points

  • Need for IP:

High Severity or Low Cognitive Level

  • No Need for IP: Low Severity and Higher Cognitive Level
slide-31
SLIDE 31

RIA Study versus ECMC Study

RIA Study ECMC Study

Location RIA Clinical Research Center ECMC Inpatient & Outpatient Chemical Dependency Programs Recruitment Source Media advertisements ECMC Clinics & Detox. Unit Treatment Staff Randomization YES NO Manualized Treatment Components YES NO Treatment fidelity monitored YES YES* Standardized treatment intensity YES YES Randomization to setting YES YES Treatment free of charge to client YES YES Blinded Research Assessments YES YES 18-month follow-up YES YES

slide-32
SLIDE 32

Treatment Intensities

Inpatient Outpatient Inpatient Days 21

  • Outpatient Sessions (21 days)
  • 6

Aftercare Sessions (6 months) 24 24

slide-33
SLIDE 33
slide-34
SLIDE 34

Sample Characteristics

Inpatient (N = 84) Outpatient (N = 92)

M SD M SD Age (years) 40.89 10.36 40.40 9.35 Gender (% female) 26 27 White race/ethnicity (%) 66 61 Employed full time (%) 26 26 Education (years) 12.06 1.75 12.24 2.15 Married/Cohabiting (%) 30 30 ECMC clinic source (% Detox) 46 53 Prior inpatient ADT (%) 52 57 Prior outpatient ADT (%) 63 73

slide-35
SLIDE 35

Client Attributes

Inpatient (N = 84) Outpatient (N = 92) M SD M SD AUI Alcohol Involvement 33.11 13.34 33.11 12.94 SDMT 43.60 10.69 42.52 10 26

slide-36
SLIDE 36

Monthly 12-Month Baseline Drinking-Related Measures

Inpatient (N = 84) Outpatient (N = 92)

M M % Voluntary alcohol abstinent days/mo. 31.55 27.49 % Voluntary alcohol/drug abstinent days/mo. 22.35 22.02 % Totally abstinent from alcohol/mo. 8.01 4.27 Drinks per drinking day 13.39 14.36 % Hospitalized/Incarcerated at least 1 day/mo. 13.98 11.50

slide-37
SLIDE 37

Primary AUD Monthly Outcomes

(over 18 mos.)

  • Percentage of Days Abstinent
  • Point Prevalence of Total Abstinence
  • Drinks Consumed on Days when Drinking
slide-38
SLIDE 38

Secondary AUD Monthly Outcomes

(over 18 mos.)

  • Point Prevalence of Any Hospitalization,

IP/Residential Treatment, or Incarceration

slide-39
SLIDE 39

What we found.

slide-40
SLIDE 40

Partial Replication for AUD Severity

  • Percentage of Days Abstinent
  • Point Prevalence of Total Abstinence
  • Drinks Consumed on Days when Drinking
slide-41
SLIDE 41

Drinks per Drinking Day

slide-42
SLIDE 42

Drinks per Drinking Day

slide-43
SLIDE 43
slide-44
SLIDE 44

Treatment Expectancy

(after randomization—before treatment) 6-item, 10-point scale rating their scheduled treatment on:

  • 1. It’s reasonableness
  • 2. Their confidence in its helpfulness
  • 3. Whether they would recommend it to a friend
  • 4. How similar it was to that expected
  • 5. The expected ease of participating
  • 6. Their overall satisfaction with the treatment scheduled
slide-45
SLIDE 45

Treatment Expectancies

7.4 7.5 7.6 7.7 7.8 7.9 8 8.1 8.2 8.3 8.4 Inpatient Outpatient

slide-46
SLIDE 46

Percentage of Days Abstinent

slide-47
SLIDE 47

Percentage of Days Abstinent

slide-48
SLIDE 48

Percentage of Days Abstinent

slide-49
SLIDE 49

Percentage of Days Abstinent

slide-50
SLIDE 50

Point-Prevalence of Monthly Abstinence

slide-51
SLIDE 51

Point Prevalence of a Subsequent Hospital Admission, IP Treatment, or Incarceration

slide-52
SLIDE 52

Point Prevalence of a Subsequent Hospital Admission, IP Treatment, or Incarceration

slide-53
SLIDE 53

Point Prevalence of a Subsequent Hospital Admission, IP Treatment, or Incarceration

slide-54
SLIDE 54

Point Prevalence of a Subsequent Hospital Admission, IP Treatment, or Incarceration

slide-55
SLIDE 55

Conclusions

slide-56
SLIDE 56

Key Question #1

  • 1. Does Inpatient Treatment for AUD Produce

Better Outcomes that Outpatient Treatment for All Comers?

a) If so, how big is the advantage?

slide-57
SLIDE 57

Key Question #2

  • 2. Does Inpatient Treatment for AUD Produce

Better Outcomes than Outpatient Treatment Among Identifiable Subgroups of Clients?

a) If so, how big is the advantage?

slide-58
SLIDE 58

Remaining Issues

  • 1. What is the optimum severity measure?
  • 2. Why do inpatients do better initially? Why

does the effect deflate over time?

  • 3. Expectancy: Timing? Why only for

inpatients?

  • 4. Cost analyses?
slide-59
SLIDE 59

Remaining Issues (Cont.)

  • 5. Representativeness of the sample?
  • 6. How would results be influenced by

medication for AUD?

  • 7. Results say nothing about treatment setting

for AUD’d adolescents

slide-60
SLIDE 60

Clinical Implications

  • Inpatient may still be the treatment of choice

for those with more severe problems.

  • If a client has high expectations that inpatient

is what they need, seriously consider giving it to them!

slide-61
SLIDE 61

Thank You!